Updated 10:20 GMT, 16 Nov 2026 SPX 7,561.67 -0.40% NDX 27,943.74 -1.22% VIX 20.14 +4.35% GOLD 3,866.50 -0.51% CL 88.41 -0.17% BTC 64,365.95 -1.44%
NAS100 27,944 −1.22% S&P 7,562 −0.40% GOLD $3,867 −0.51% BTC $64,366 −1.44% VIX 20.14 +4.35% latest tape · as of 10:20 UTC
The Screen · Financials · Asset Management

Fidelity Emerging Markets Limited

FEML.L · LSE · GBp · Market cap $61.0B

Fidelity Emerging Markets Limited is a closed ended equity mutual fund launched by Genesis Asset Managers, LLP.

FAIL · Does not pass the screen
1,206.00 GBp

Price as of 13 Nov 2026Daily close, not a live quote

Screened 2026-11-13 · the tape above runs as of 10:20 UTC · two dates, stated on purpose · verdict and workings shown in full · never trimmed

Key facts today

  • Price1,206.00 GBp at the 13 Nov 2026 close
  • Our regime readDistribution, as of 15 Nov 2026
  • Ethical screenDoes not pass
  • Last reviewed13 Nov 2026 (3 days ago)
  • Release timesRelease and earnings times on your chart: Event Guard Mentor

A summary of the dated readings below, not a live quote and not advice.

FAIR-VALUE RANGE

Our fair-value range: range not available (screen dated 2026-11-13).

Current read
Distribution ?
Screened · screened 2026-11-13
  • Trend Distribution
  • Insiders no filings inside 60 days, left as found
  • Positioning no disclosures inside 60 days, left as found
  • Options no verdict drawn today, left as found
  • Ethical does not pass the values gate
Price1,206.00 GBp
Ethical score30.0/100
Our investment reviews on this name
2026-10-26Read Distribution1,498.00-19.5% to today ✓Markup gives way to Distribution after a 5% rise in 8 weeks
2026-08-29Read Markup1,420.00-15.1% to today Distribution gives way to Markup first Markup read since July
2026-07-28Read Distribution1,420.00-15.1% to today ✓Markup gives way to Distribution
2026-07-02Read Markup1,420.00-15.1% to today First review on file: Markup

Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.

The full research record, in depth, below
The Label · The Season, Not the Day

This name holds its distribution label.

Fidelity Emerging Markets Limited holds its Distribution at $1,206.00. Elevated stress, defensive posture warranted, held for 19 days.

As held on the ledger · 2026-11-13
PhaseDistribution · caution
Quantitative stateElevated stress, defensive posture warranted, held for 19 days
Price at the screen$1,206.00
Valuation407.07 trailing · N/A forward price to earnings
Values screenFAIL · score 30.0
Beta0.71
The Workings

Five Screens, Shown in Full

Does not pass. Prohibited keyword in sector/industry: financial services

TestFigureLimitWhat it meansStatus
Business activity Excluded Core business clean Prohibited keyword in sector/industry: financial services Fail
Debt load Excluded Below 33% Interest-bearing debt is of its assets, above the one-third ceiling the screen allows. Fail
Interest-bearing cash Excluded Below 33% Interest-bearing cash and securities are of assets, above the one-third limit. Fail
Receivables Excluded Below 49% Money owed to the company is of assets, above the 49% limit. Fail
Revenue purity Excluded Below 5% of revenue comes from non-compliant sources, over the 5% line. Fail

Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.

The Ethical Read

Why It Falls Short, in Plain English

Fidelity Emerging Markets does not clear the screen at the business-activity stage. It operates in conventional financial services, which the screen treats as interest-based, so the financial ratios are not the deciding factor here.

Read as at 2026-11-15. It updates when the underlying figures move, and past reads are kept below.

Follow this verdict

Get an email when FEML.L's ethical verdict changes

Today FEML.L does not pass the screen. If new figures move it to a pass, we send you one short email with the before and after. Verdicts change rarely, so you may not hear from us for a long time.

Free, no account needed. Every email has a link to stop.

The Business, in Plain Words
The fundamentals · plain-English read
Trailing P/E407.1xexpensive: the price assumes strong growth ahead
EPS, trailing3.68
Profit margin132.4%highly profitable on every dollar of sales
Return on equity45.7%an exceptional return on shareholder capital
FCF yield19.52%
Dividend yield1.35%
Current ratio5.14comfortably covers its short-term bills
Beta0.71steadier than the market
52-week range757.00 - 1,568.99
Market cap$61.0B

Another profit measure, before interest, tax and non-cash costs: EBITDA.

The risks · The things to watch: its business and earnings are exposed to United Kingdom and to currency swings.

Plain-English interpretation of our own screen data. Analysis, not advice.

Where & How to Trade

FEML.L trades on LSE (the company is based in United Kingdom). As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.

The Dated Journal · Newest First, Never Edited

Every Entry, As Written

2026-11-06 Distribution $1,254.00 -16.3% Entry 9

The analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 16.3% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is holding around 8% above its long-term trend line with momentum reading oversold. Over the past year the shares are up 77%. Our forward projection puts the odds of a 10% gain over the next month near 19%.

2026-10-26 Distribution · changed $1,498.00 +0.0% Entry 8

The framework has shifted from markup to distribution since the last review. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 8% above its long-term trend line with momentum reading oversold. Over the past year the shares are up 77%. Our forward projection puts the odds of a 10% gain over the next month near 19%.

2026-10-17 Markup $1,498.00 +0.0% Entry 7

The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 33% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 77%. Our forward projection puts the odds of a 10% gain over the next month near 19%.

2026-10-02 Markup $1,498.00 +5.5% Entry 6

Our analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 5.5% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 33% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 77%. Our forward projection puts the odds of a 10% gain over the next month near 19%.

2026-08-29 Markup · changed $1,420.00 +0.0% Entry 5

The framework has shifted from distribution to markup since the last review. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 33% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 77%. Our forward projection puts the odds of a 10% gain over the next month near 19%.

2026-07-28 Distribution · changed $1,420.00 +0.0% Entry 4

The framework has shifted from markup to distribution since the last review. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it A, carrying a low risk profile. Technically it is holding around 33% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 77%. Our forward projection puts the odds of a 10% gain over the next month near 19%.

2026-07-18 Markup $1,420.00 +0.0% Entry 3

Our analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it A, carrying a low risk profile. Technically it is holding around 33% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 77%. Our forward projection puts the odds of a 10% gain over the next month near 19%.

2026-07-03 Markup $1,420.00 +0.0% Entry 2

Our analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns.

2026-07-02 Markup $1,420.00 Entry 1

Our analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns.

Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.

What Holding Actually Paid · Price Plus Dividends
If $1,000 had been placed · historical, not a promise
PeriodPrice thenPrice returnDivs per share$1,000 becameTotal return
1 month $1,422.00 -3.4% · $966 -3.4%
2 months $1,254.00 +9.6% · $1,096 +9.6%
3 months $1,204.00 +14.1% · $1,141 +14.1%
6 months $1,008.00 +36.3% · $1,363 +36.3%
1 year $775.84 +77.1% $19.80 $1,797 +79.7%
2 years $680.71 +101.9% $35.54 $2,071 +107.1%
3 years $601.59 +128.4% $50.81 $2,368 +136.8%
5 years $934.02 +47.1% $77.83 $1,554 +55.4%

Historical returns from market close data. Past performance does not guarantee future results.

The Ledger's Promise

This entry now belongs to the ledger. Whatever FEML.L does next, these words stay.

Fidelity Emerging Markets Limited · FEML.L · Distribution · $1,206.00
Recorded 2026-11-13 · before the outcome · scored mechanically

Membership

Thirteen thousand names carry this page. One desk keeps them honest.

Membership opens the full screen archive, the composites built from it, and the daily coverage that prices what the screen approves.

Join the desk

Screening is research, not a fatwa and not financial advice. Figures are drawn from public accounts at the screen date shown. Always manage your risk.

Get our weekly market brief free.